Literature DB >> 458191

Photoinactivation of skin fibroblasts by fractionated treatment with 8-methoxypsoralen and UVA.

J Pohl, E Christophers.   

Abstract

Guinea pig skin fibroblasts treated with low doses of 8-methoxypsoralen (8-MOP) and long-wave ultraviolet light (UVA) showed a dose-dependent inhibition of 3H-Thymidine incorporation as determined by liquid scintillation counting. The minimum incubation time necessary to obtain constant inhibition rates was 60 min. By washing the drug was removed from the reactive sites within 30 min. Repeated light exposure at a constant concentration of 8-MOP caused a cumulative inhibition of DNA synthesis. Irradiation of 8-MOP-plus-UVA treated cells, from which the drug was removed, produced a small increase in photoinhibition. Split dose treatment at various time intervals (ranging from 1--48 hr) revealed inhibitory rates, which correspond to the total amount of UVA applied. No recovery effects were seen in cultures treated by single or multiple applications of 8-MOP-plus-UVA.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 458191     DOI: 10.1111/1523-1747.ep12581643

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

1.  [8-Methoxypsoralen (8-MOP)-a new galenic form and its relation to 8-MOP serum levels (author's transl)].

Authors:  V Nitsche; M Raff; H Bardach
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

2.  Inhibitory effect of 8-methoxysporalen plus UVA (PUVA) on the systemic induction of contact sensitivity to dinitrochlorobenzene (DNCB) in guinea pigs.

Authors:  J C Meyer; H P Grundmann; H Weiss
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

3.  The effects of long-term local PUVA treatment on collagen metabolism in human skin.

Authors:  N Väätäinen; A Oikarinen; E R Kuutti-Savolainen
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

4.  Action spectra for 8-methoxypsoralen and 3-carbethoxypsoralen in skin fibroblasts in vitro.

Authors:  E Christophers; B Schmidt
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

5.  Pharmacokinetic and clinical comparison of two 8-methoxypsoralen brands.

Authors:  K E Andersen; T Menne; M Gammeltoft; N Hjorth; E Larsen; P Solgaard
Journal:  Arch Dermatol Res       Date:  1980       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.